Po‐Ku Chen

424 total citations
35 papers, 318 citations indexed

About

Po‐Ku Chen is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Po‐Ku Chen has authored 35 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 15 papers in Hematology and 14 papers in Molecular Biology. Recurrent topics in Po‐Ku Chen's work include Autoimmune and Inflammatory Disorders Research (13 papers), Inflammasome and immune disorders (9 papers) and Immune Cell Function and Interaction (7 papers). Po‐Ku Chen is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (13 papers), Inflammasome and immune disorders (9 papers) and Immune Cell Function and Interaction (7 papers). Po‐Ku Chen collaborates with scholars based in Taiwan, Japan and United States. Po‐Ku Chen's co-authors include Der‐Yuan Chen, Der‐Yuan Chen, Joung‐Liang Lan, Kuo‐Tung Tang, Chu‐Huang Chen, Tsai‐Ling Liao, Yi‐Ming Chen, Hui‐Ju Lin, Hung‐Jen Liu and Ni Tien and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Po‐Ku Chen

33 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Po‐Ku Chen Taiwan 13 133 121 82 56 44 35 318
Satish Kumar Devarapu Germany 11 120 0.9× 164 1.4× 22 0.3× 66 1.2× 32 0.7× 17 384
Dominik Majewski Poland 10 88 0.7× 97 0.8× 31 0.4× 120 2.1× 33 0.8× 31 325
Lidia La Barbera Italy 7 93 0.7× 152 1.3× 47 0.6× 117 2.1× 34 0.8× 26 342
Long Chu United States 8 142 1.1× 189 1.6× 25 0.3× 18 0.3× 27 0.6× 10 318
Kathrin Schwierczek Germany 4 63 0.5× 91 0.8× 134 1.6× 11 0.2× 30 0.7× 5 345
Sara Assadiasl Iran 11 63 0.5× 82 0.7× 17 0.2× 37 0.7× 25 0.6× 35 301
Hideki Takano Japan 7 82 0.6× 33 0.3× 55 0.7× 20 0.4× 74 1.7× 21 338
Sandrine Laurance France 11 84 0.6× 134 1.1× 120 1.5× 9 0.2× 16 0.4× 24 402

Countries citing papers authored by Po‐Ku Chen

Since Specialization
Citations

This map shows the geographic impact of Po‐Ku Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐Ku Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐Ku Chen more than expected).

Fields of papers citing papers by Po‐Ku Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po‐Ku Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐Ku Chen. The network helps show where Po‐Ku Chen may publish in the future.

Co-authorship network of co-authors of Po‐Ku Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Po‐Ku Chen. A scholar is included among the top collaborators of Po‐Ku Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po‐Ku Chen. Po‐Ku Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Po‐Ku, et al.. (2025). Toward a personalized therapy of still’s disease based on immunologic endotypes: a narrative review. Expert Review of Clinical Immunology. 21(4). 401–412.
2.
Chen, Po‐Ku, Wei‐Fan Hsu, Cheng‐Yuan Peng, et al.. (2024). Significant association of elevated serum galectin-9 levels with the development of non-alcoholic fatty liver disease in patients with rheumatoid arthritis. Frontiers in Medicine. 11. 1347268–1347268. 1 indexed citations
3.
Li, Yi‐Chen, et al.. (2024). Elevated remnant cholesterol as a potential predictor for cardiovascular events in rheumatoid arthritis patients. Frontiers in Cardiovascular Medicine. 11. 1449219–1449219. 1 indexed citations
4.
Chen, Po‐Ku, Kuo‐Tung Tang, & Der‐Yuan Chen. (2024). The NLRP3 Inflammasome as a Pathogenic Player Showing Therapeutic Potential in Rheumatoid Arthritis and Its Comorbidities: A Narrative Review. International Journal of Molecular Sciences. 25(1). 626–626. 14 indexed citations
5.
6.
Chen, Po‐Ku, Yi‐Ming Chen, Jeremy J.W. Chen, & Der‐Yuan Chen. (2024). Anti-peptide antibodies, anti-SNRK and anti-HUWE1 antibodies as potential predictors of good response to tofacitinib therapy in rheumatoid arthritis patients. Lara D. Veeken. 64(5). 2451–2460.
7.
Chen, Po‐Ku, Kuo‐Tung Tang, & Der‐Yuan Chen. (2023). The NLRP3 Inflammasome as a Pathogenic Player Showing Therapeutic Potential in Rheumatoid Arthritis and Its Comorbidities: A Narrative Review. Preprints.org. 2 indexed citations
8.
Chen, Po‐Ku, et al.. (2023). The detectable anti-interferon-γ autoantibodies in COVID-19 patients may be associated with disease severity. Virology Journal. 20(1). 33–33. 12 indexed citations
9.
Chen, Po‐Ku, et al.. (2023). High-titer anti-interferon-γ neutralizing autoantibodies linked to opportunistic infections in patients with adult-onset still's disease. Frontiers in Medicine. 9. 1097514–1097514. 3 indexed citations
10.
Chiang, En‐Pei Isabel, Kuang‐Hsi Chang, Kuo‐Tung Tang, et al.. (2023). The Sizes and Composition of HDL-Cholesterol Are Significantly Associated with Inflammation in Rheumatoid Arthritis Patients. International Journal of Molecular Sciences. 24(13). 10645–10645. 10 indexed citations
12.
13.
Liao, Tsai‐Ling, Yi‐Ming Chen, Kuo‐Tung Tang, et al.. (2021). MicroRNA-223 inhibits neutrophil extracellular traps formation through regulating calcium influx and small extracellular vesicles transmission. Scientific Reports. 11(1). 15676–15676. 31 indexed citations
14.
Chen, Po‐Ku, Joung‐Liang Lan, Jye‐Lin Hsu, et al.. (2021). Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still’s Disease From COVID-19. Frontiers in Immunology. 12. 719544–719544. 38 indexed citations
16.
17.
Chen, Po‐Ku, Chun‐Hung Hua, Hui‐Ting Hsu, et al.. (2018). ALPK1 Expression Is Associated with Lymph Node Metastasis and Tumor Growth in Oral Squamous Cell Carcinoma Patients. American Journal Of Pathology. 189(1). 190–199. 12 indexed citations
18.
Young, Guang‐Huar, et al.. (2015). Identification of adenine modulating AMPK activation in NIH/3T3 cells by proteomic approach. Journal of Proteomics. 120. 204–214. 13 indexed citations
19.
Young, Guang‐Huar, Jiun‐Tsai Lin, Po‐Ku Chen, et al.. (2015). Activation of AMP-Activated Protein Kinase by Adenine Alleviates TNF-Alpha-Induced Inflammation in Human Umbilical Vein Endothelial Cells. PLoS ONE. 10(11). e0142283–e0142283. 23 indexed citations
20.
Yu, I‐Shing, Mi‐Hua Tao, Guey‐Yueh Shi, et al.. (2011). Study the therapeutic effect of the high activity FIX variants using hemophilia B mouse model. Transgenic Research. 20(5). 1185–1186. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026